• Earlier this month, Target voluntarily recalled several lots of its Up & Up fragrance-free and cucumber-scented baby wipes sold nationwide after FDA testing found contamination with Burkholderia bacteria that can cause serious infections, especially in infants and young children.
• The episode highlights how quality-control failures at third-party manufacturers can quickly turn into health, reputational, and operational risks for retailers that rely heavily on owned brands.
• We’ll now examine how this baby wipes recall, and the underlying product safety and brand trust concerns, may influence Target’s investment narrative.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Target Investment Narrative Recap

To own Target, you need to believe its mix of stores, digital channels, and owned brands can keep attracting steady traffic while protecting margins. Right now, the key near term catalyst is whether recent traffic and comparable sales gains can hold up, and the biggest risk is that quality or safety issues in owned brands undermine that progress. The baby wipes recall introduces reputational and operational noise, but at this stage it does not appear to be a financially material hit.

The most relevant recent update is Target’s first quarter 2026 report, which showed customer traffic up 4.4% and comparable sales up 5.6%. Those numbers underline how important owned brands and guest trust are to the current rebound story. Any questions about product safety or quality, even if isolated to a single supplier, could affect how durable that traffic improvement and broader merchandising momentum prove to be.

Yet beneath the recent traffic gains, investors should be aware of how dependent the story still is on owned brand execution and...

Target's narrative projects $110.5 billion revenue and $3.7 billion earnings by 2028. This requires 1.4% yearly revenue growth and a $0.5 billion earnings decrease from $4.2 billion today.

Uncover how Target's forecasts yield a $96.52 fair value, a 22% downside to its current price.

Exploring Other Perspectives

Before this recall, the most optimistic analysts were assuming Target could lift annual revenue to about US$120.4 billion and earnings to roughly US$4.6 billion, but events like a baby wipes contamination highlight how differing views on product safety and private label risk can lead you to a very different conclusion about that upside.

Explore 12 other fair value estimates on Target - why the stock might be worth as much as 28% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Target research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Target research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Target's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Uncover the next big thing with 23 elite penny stocks that balance risk and reward.
• Find 47 companies with promising cash flow potential yet trading below their fair value.
• Explore 30 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.